Hirashima Y - Search Results

1

Analysis of plasma and hematoma lipids related to choline glycerophospholipid in patients with chronic subdural hematoma.

Hirashima Y, Nagahori T, Nishijima M, Endo S, Takaku A, Nakagawa Y. Hirashima Y, et al. Neurol Med Chir (Tokyo). 1994 Mar;34(3):131-5. doi: 10.2176/nmc.34.131. Neurol Med Chir (Tokyo). 1994. PMID: 7516041 Free article.

2

Sequential changes in the platelet count in patients with symptomatic vasospasm after subarachnoid hemorrhage.

Hirashima Y, Hayashi N, Endo S, Takaku A. Hirashima Y, et al. Neurol Med Chir (Tokyo). 1993 Apr;33(4):220-4. doi: 10.2176/nmc.33.220. Neurol Med Chir (Tokyo). 1993. PMID: 7685852 Free article.

3

Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers.

Hirashima Y, Endo S, Hayashi N, Karasawa K, Nojima S, Takaku A. Hirashima Y, et al. Acta Neurochir (Wien). 1995;137(1-2):15-8. doi: 10.1007/BF02188773. Acta Neurochir (Wien). 1995. PMID: 8748861

4

Elevated plasma basic fibroblast growth factor in brain tumor patients.

Kurimoto M, Endo S, Hirashima Y, Nishijima M, Takaku A. Kurimoto M, et al. Among authors: hirashima y. Neurol Med Chir (Tokyo). 1996 Dec;36(12):865-8; discussion 869. doi: 10.2176/nmc.36.865. Neurol Med Chir (Tokyo). 1996. PMID: 9002714 Free article.

5

Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety.

Hirashima Y, Endo S, Nukui H, Kobayashi N, Takaku A. Hirashima Y, et al. Neurol Med Chir (Tokyo). 2001 Apr;41(4):165-75; discussion 175-6. doi: 10.2176/nmc.41.165. Neurol Med Chir (Tokyo). 2001. PMID: 11381675 Free article. Clinical Trial.

6

Immunofluorescent localization of platelet-activating factor (PAF) in the rat.

Hirashima Y, Kato R, Endo S, Takaku A, Karasawa K, Nojima S. Hirashima Y, et al. Histochem J. 1993 Nov;25(11):830-3. Histochem J. 1993. PMID: 7507910

7

Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.

Hirashima Y, Endo S, Kurimoto M, Tsukamoto E, Takaku A. Hirashima Y, et al. Acta Neurochir (Wien). 1994;128(1-4):144-9. doi: 10.1007/BF01400665. Acta Neurochir (Wien). 1994. PMID: 7847132

8

An experimental model of symptomatic vasospasm induced by oxyhemoglobin in rabbits.

Otsuji T, Endo S, Hirashima Y, Nishijima M, Takaku A. Otsuji T, et al. Among authors: hirashima y. Stroke. 1994 Mar;25(3):657-62. doi: 10.1161/01.str.25.3.657. Stroke. 1994. PMID: 8128522

9

Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.

Hirashima Y, Endo S, Ohmori T, Kato R, Takaku A. Hirashima Y, et al. J Neurosurg. 1994 Jan;80(1):31-6. doi: 10.3171/jns.1994.80.1.0031. J Neurosurg. 1994. PMID: 8271019

10

Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.

Hirashima Y, Endo S, Otsuji T, Karasawa K, Nojima S, Takaku A. Hirashima Y, et al. J Neurosurg. 1993 Apr;78(4):592-7. doi: 10.3171/jns.1993.78.4.0592. J Neurosurg. 1993. PMID: 8450333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters